Avian influenza outbreaks on US dairy farms have raised concerns about milk safety, leading some to consider alternatives like engineered milk proteins. Startups like Remilk and Alpine Bio are using yeast and soybeans to produce key milk proteins, aiming to replace dairy cows and reduce environmental impact. However, competing with subsidized dairy industries and their efficient use of cow byproducts remains a challenge for these biotech ventures, MIT Technology Review reports. The story adds: Everyone agrees that cow's milk will be difficult to displace. It holds a special place in the human psyche, and we owe civilization itself, in part, to domesticated animals. In fact, they've left their mark in our genes, with many of us carrying DNA mutations that make cow's milk easier to digest. But that's why it might be time for the next technological step, says Alpine's CEO Magi Richani. "We raise 60 billion animals for food every year, and that is insane. We took it too far, and we need options," she says. "We need options that are better for the environment, that overcome the use of antibiotics, and that overcome the disease risk." It's not clear yet whether the bird flu outbreak on dairy farms is a big danger to humans. But making milk without cows would definitely cut the risk that an animal virus will cause a new pandemic. As Richani says: "Soybeans don't transmit diseases to humans."

An anonymous reader quotes a report from the New York Times: A committee of independent advisers to the Food and Drug Administration voted unanimously on Monday that the benefits outweigh the risks of the newest experimental drug for Alzheimer's disease. Alzheimer's afflicts more than six million Americans. It has no cure, and there is no treatment or lifestyle modification that can restore memory loss or reverse cognitive decline. The drug, made by Eli Lilly, is donanemab. It modestly slowed cognitive decline in patients in the early stages of the disease but also had significant safety risks, including swelling and bleeding in the brain. The committee concluded, though, that the consequences of Alzheimer's are so dire that even a modest benefit can be worthwhile.

The F.D.A. usually follows the advice of the agency's advisory committees but not always. The drug is based on a long-held hypothesis that Alzheimer's disease begins when rough hard balls of amyloid, a protein, pile up in patients' brains, followed by a cascade of reactions leading to the death of neurons. The idea is to treat Alzheimer's by attacking amyloid, clearing it from the brain. Two similar amyloid-fighting drugs were approved recently: Leqembi, made by Eisai and Biogen, was approved last year. That drug's risks and modest benefits are similar to those of donanemab. Aduhelm, made by Biogen, is the other drug and was approved in 2021 but was discontinued because there was insufficient evidence that it could benefit patients. Donanemab was expected to be approved earlier this year, but in March, the F.D.A. decided that, instead, it would require donanemabto undergo the scrutiny of an independent advisory committee, a surprise to Eli Lilly.

The vote, said Dr. Daniel Skovronsky, chief scientific officer at Lilly, confirmed his 25-year quest to find a way to intervene in the Alzheimer's disease. Now, he said, the company is starting a study that, it hopes, will stop the disease before symptoms even begin. At issue before the committee on Monday were some unusual aspects of donanemab's clinical trials, especially that study participants stopped taking the drug as soon as their amyloid was cleared. Some experts questioned whether stopping was the best strategy and whether clinical practice should include halting the treatment after amyloid clearance.

Victoria Song reports via The Verge: Samsung Electronics workers went on a strike on Friday for the very first time in the company's history. The move comes at a time when the Korean corporation faces increased competition from other chipmakers, particularly as demand for AI chips grows. The National Samsung Electronics Union (NSEU), the largest of the company's several unions, called for the one-day strike at Samsung's Seoul office building as negotiations over pay bonuses and time off hit a standstill. The New York Times reports that the majority of striking workers come from Samsung's chip division. (Samsung Electronics is technically only a subsidiary comprising its consumer tech, appliances, and semiconductor divisions; Samsung itself is a conglomerate that controls real estate, retail, insurance, food production, hotels, and a whole lot more.) It's unclear how many of the NSEU's roughly 28,400 members participated in the walkout. Even so, multiple outlets are reporting that the walkout is unlikely to affect chip production or trigger shortages. Union leaders told Bloomberg that further actions are planned if management refuses to engage.

That said, the fact that it's happening at all is awkward timing for Samsung, particularly due to tensions with the chipmaking portion of its business. Last year, the division reported a 15 trillion won ($11 billion) loss, leading to a 15-year low in operating profits. The current AI boom played a big role in the massive loss. Samsung has historically been the world leader in making high-bandwidth memory chips â" the kind that are in demand right now to power next-gen generative AI features. However, last year's decline was partly because Samsung wasn't prepared for increased demand, allowing local rival SK Hynix to take the top spot.

Will appetite-suppressing drugs hurt the sugar industry? Executives from Walmart warned that Ozempic and Zepbound "are impacting food sales," reports Bloomberg, "and multiple analyst surveys have showed that less-hungry customers are spending fewer dollars at grocery stores and restaurants." The drugs, which cut cravings, will result in a decline in calorie consumption in the US of 1.5% to 2.5% by 2035, with a drop of as much as 5% in the consumption of sweets such as baked goods, confectionery and soda, Morgan Stanley analysts including Pamela Kaufman said in a report last month. Morgan Stanley forecast about a 10th of the US population will be on the so-called GLP-1 medications — originally designed to treat diabetes but being used by many as a powerful weight-loss tool — by 2035... Even with tight supplies and sky-high prices limiting uptake of the medications, sales of GLP-1 drugs for both obesity and diabetes already exceeded $19 billion in 2023. The global obesity market alone could top $100 billion by the end of the decade, Goldman Sachs Group Inc. estimates, while Bloomberg Intelligence forecasts $80 billion of sales.

More than 60% of US consumers taking the drugs said they had cut back on sweet treats like candy, ice cream and baked goods, and many said they had either significantly — or entirely — stopped eating those products, according to Morgan Stanley.

Now included in Amazon Prime is free delivery via Grubhub. According to The Verge, "Amazon is now embedding Grubhub into Amazon.com and the Amazon Shopping app, and Amazon Prime customers paying $139 per year for Amazon Prime will now pay $0 for food delivery fees on orders of $12 or more, among other benefits." From the report: Amazon had previously offered Prime customers a free one-year subscription to GrubHub Plus, but that one auto-renewed at $129 per year. Now, it's a permanent part of the Amazon Prime subscription. Amazon says the ordering experience is "identical" to ordering from Grubhub's website or app and is accessible to all customers, even without Prime. Amazon and Grubhub say they'll continue collaborating on other promotions, including food pairings and promotions like the limited Nuka burger for the Fallout series premiere. Prime members can also get $5 off their Grubhub meal of $25 or more made through Amazon with code PRIME5 (valid through June 2nd). What will likely not be included in Amazon's Prime subscription is Alexa's upcoming AI overhaul. "Amazon is upgrading its decade-old Alexa voice assistant with generative AI and plans to charge a monthly subscription fee to offset the cost of the technology," CNBC reported earlier this month. Unfortunately, sources said it will not be included in the $139-per-year Prime offering.

Some of the world's most profitable -- and most polluting corporations -- have invested in carbon offset projects that have fundamental failings and are "probably junk," suggesting industry claims about greenhouse gas reductions were likely overblown, according to new analysis. From a report: Delta, Gucci, Volkswagen, ExxonMobil, Disney, easyJet and Nestle are among the major corporations to have purchased millions of carbon credits from climate friendly projects that are "likely junk" or worthless when it comes to offsetting their greenhouse gas emissions, according to a classification system developed by Corporate Accountability, a non-profit, transnational corporate watchdog. Some of these companies no longer use CO2 offsets amid mounting evidence that carbon trading do not lead to the claimed emissions cuts -- and in some cases may even cause environmental and social harms.

However, the multibillion-dollar voluntary carbon trading industry is still championed by many corporations including oil and gas majors, airlines, automakers, tourism, fast-food and beverage brands, fashion houses, banks and tech firms as the bedrock of climate action -- a way of claiming to reduce their greenhouse gas footprint while continuing to rely on fossil fuels and unsustainable supply chains. Yet, for 33 of the top 50 corporate buyers, more than a third of their entire offsets portfolio is "likely junk" -- suggesting at least some claims about carbon neutrality and emission reductions have been exaggerated according to the analysis. The fundamental failings leading to a "likely junk" ranking include whether emissions cuts would have happened anyway, as is often the case with large hydroelectric dams, or if the emissions were just shifted elsewhere, a common issue in forestry offset projects.

An anonymous reader quotes a report from the New York Times: The defense lawyer minced no words as he addressed a room full of plastic-industry executives. Prepare for a wave of lawsuits with potentially "astronomical" costs. Speaking at a conference earlier this year, the lawyer, Brian Gross, said the coming litigation could "dwarf anything related to asbestos," one of the most sprawling corporate-liability battles in United States history. Mr. Gross was referring to PFAS, the "forever chemicals" that have emerged as one of the major pollution issues of our time. Used for decades in countless everyday objects -- cosmetics, takeout containers, frying pans -- PFAS have been linked to serious health risks including cancer. Last month the federal government said several types of PFAS must be removed from the drinking water of hundreds of millions of Americans. "Do what you can, while you can, before you get sued," Mr. Gross said at the February session, according to a recording of the event made by a participant and examined by The New York Times. "Review any marketing materials or other communications that you've had with your customers, with your suppliers, see whether there's anything in those documents that's problematic to your defense," he said. "Weed out people and find the right witness to represent your company."

A wide swath of the chemicals, plastics and related industries are gearing up to fight a surge in litigation related to PFAS, or per- and polyfluoroalkyl substances, a class of nearly 15,000 versatile synthetic chemicals linked to serious health problems. [...] PFAS-related lawsuits have already targeted manufacturers in the United States, including DuPont, its spinoff Chemours, and 3M. Last year, 3M agreed to pay at least $10 billion to water utilities across the United States that had sought compensation for cleanup costs. Thirty state attorneys general have also sued PFAS manufacturers, accusing the manufacturers of widespread contamination. But experts say the legal battle is just beginning. Under increasing scrutiny are a wider universe of companies that use PFAS in their products. This month, plaintiffs filed a class-action lawsuit against Bic, accusing the razor company for failing to disclose that some of its razors contained PFAS. Bic said it doesn't comment on pending litigation, and said it had a longstanding commitment to safety.

The Biden administration has moved to regulate the chemicals, for the first time requiring municipal water systems to remove six types of PFAS. Last month, the Environmental Protection Agency also designated two of those PFAS chemicals as hazardous substances under the Superfund law, shifting responsibility for their cleanup at contaminated sites from taxpayers to polluters. Both rules are expected to prompt a new round of litigation from water utilities, local communities and others suing for cleanup costs. "To say that the floodgates are opening is an understatement," said Emily M. Lamond, an attorney who focuses on environmental litigation at the law firm Cole Schotz. "Take tobacco, asbestos, MTBE, combine them, and I think we're still going to see more PFAS-related litigation," she said, referring to methyl tert-butyl ether, a former harmful gasoline additive that contaminated drinking water. Together, the trio led to claims totaling hundreds of billions of dollars. Unlike tobacco, used by only a subset of the public, "pretty much every one of us in the United States is walking around with PFAS in our bodies," said Erik Olson, senior strategic director for environmental health at the Natural Resources Defense Council. "And we're being exposed without our knowledge or consent, often by industries that knew how dangerous the chemicals were, and failed to disclose that," he said. "That's a formula for really significant liability."

Studies show ultraprocessed food "encourages overeating but may leave the eater undernourished," writes Ars Technica.

But the food industry's response has been "a ferocious campaign against regulation." In part it has used the same lobbying playbook as its fight against labeling and taxation of "junk food" high in calories: big spending to influence policymakers. FT analysis of US lobbying data from non-profit Open Secrets found that food and soft drinks-related companies spent $106 million on lobbying in 2023, almost twice as much as the tobacco and alcohol industries combined. Last year's spend was 21 percent higher than in 2020, with the increase driven largely by lobbying relating to food processing as well as sugar.

In an echo of tactics employed by cigarette companies, the food industry has also attempted to stave off regulation by casting doubt on the research of scientists like [Brazilian nutritional scientist Carlos] Monteiro. "The strategy I see the food industry using is deny, denounce, and delay," says Barry Smith, director of the Institute of Philosophy at the University of London and a consultant for companies on the multisensory experience of food and drink.

So far the strategy has proved successful. Just a handful of countries, including Belgium, Israel, and Brazil, currently refer to UPFs in their dietary guidelines. But as the weight of evidence about UPFs grows, public health experts say the only question now is how, if at all, it is translated into regulation. "There's scientific agreement on the science," says Jean Adams, professor of dietary public health at the MRC Epidemiology Unit at the University of Cambridge. "It's how to interpret that to make a policy that people aren't sure of."

[...] As researchers have learned more about the link between UPFs and poor health outcomes, companies have remained largely silent about these risks, leaving trade bodies that advocate on their behalf to argue loudly against the validity of the research.

Scientists report that Greater Spotted Eagles altered their migration routes across Ukraine to avoid conflict and habitat destruction caused by the war. The BBC reports: The scientists studied GPS data from tagged birds in the months after the February 2022 invasion, a time of heavy fighting in northern Ukraine as Russia tried to take Kyiv by sending troops south from Belarus. The researchers from the Estonian University of Life Sciences and the British Trust for Ornithology reported their findings in the journal Current Biology. "The war in Ukraine has had a devastating impact on people and the environment. Our findings provide a rare window into how conflicts affect wildlife," said lead author Charlie Russell, a postgraduate researcher at the University of East Anglia.

Classified as a vulnerable species, the Greater Spotted Eagle is a large, brownish-colored bird of prey. Researchers started following them using GPS tracking devices in 2017 but didn't expect to be monitoring them through an active conflict zone five years later. The findings reveal they made large deviations from their previously tracked routes. They also spent less time stopping at their usual refueling sites in Ukraine or avoided them entirely. As a result, they traveled farther, about an extra 52 miles (85km) on average.

For migrating birds, stopover sites are essential places to get food, water, and shelter. These changes delayed the birds' arrival at the breeding grounds and likely made them use more energy, to damaging effect. "No doubt about it. I think the take-home story is that the conflict in Ukraine is fundamentally disrupting the migratory ecology of this species," said Dr Jim Reynolds, Assistant Professor in Ornithology and Animal Conservation at the University of Birmingham, who was independent from the study. "For a vulnerable species like this, anything that disrupts breeding performance is a major problem. As a conservation biologist, you worry about that in a massive way." Despite all the tagged birds surviving, researchers believe their experience may have affected their ability to breed.

An anonymous reader quotes a report from The Guardian: Hopes that replacement fuels for airplanes will slash carbon pollution are misguided and support for these alternatives could even worsen the climate crisis, a new report has warned. There is currently "no realistic or scalable alternative" to standard kerosene-based jet fuels, and touted "sustainable aviation fuels" are well off track to replace them in a timeframe needed to avert dangerous climate change, despite public subsidies, the report by the Institute for Policy Studies, a progressive thinktank, found. "While there are kernels of possibility, we should bring a high level of skepticism to the claims that alternative fuels will be a timely substitute for kerosene-based jet fuels," the report said. [...]

In the U.S., Joe Biden's administration has set a goal for 3 billion gallons of sustainable aviation fuel, which is made from non-petroleum sources such as food waste, woody biomass and other feedstocks, to be produced by 2030, which it said will cut aviation's planet-heating emissions by 20%. [...] Burning sustainable aviation fuels still emits some carbon dioxide, while the land use changes needed to produce the fuels can also lead to increased pollution. Ethanol biofuel, made from corn, is used in these fuels, and meeting the Biden administration's production goal, the report found, would require 114m acres of corn in the U.S., about a 20% increase in current land area given over to to the crop. In the UK, meanwhile, 50% of all agricultural land will have to be given up to sustain current flight passenger levels if jet fuel was entirely replaced. "Agricultural land use changes could threaten global food security as well as nature-based carbon sequestration solutions such as the preservation of forests and wetlands," the report states. "As such, SAF production may actively undermine the Paris agreement goal of achieving greatly reduced emissions by 2050." Chuck Collins, co-author of the report, said: "To bring these fuels to the scale needed would require massive subsidies, the trade-offs would be unacceptable and would take resources aware from more urgent decarbonization priorities."

"It's a huge greenwashing exercise by the aviation industry. It's magical thinking that they will be able to do this."

Phil Ansell, director of the Center for Sustainable Aviation at the University of Illinois, added: "There's an underappreciation of how big the energy problem is for aviation. We are still many years away from zero pollution flights. But it's true that the industry has been slow to pick things up. We are now trying to find solutions, but we are working at this problem and realizing it's a lot harder than we thought. We are late to the game. We are in the dark ages in terms of sustainability, compared to other sectors."

Microplastics have been found in human testicles, with researchers saying the discovery might be linked to declining sperm counts in men. From a report: The scientists tested 23 human testes, as well as 47 testes from pet dogs. They found microplastic pollution in every sample. The human testicles had been preserved and so their sperm count could not be measured. However, the sperm count in the dogs' testes could be assessed and was lower in samples with higher contamination with PVC. The study demonstrates a correlation but further research is needed to prove microplastics cause sperm counts to fall.

Sperm counts in men have been falling for decades, with chemical pollution such as pesticides implicated by many studies. Microplastics have also recently been discovered in human blood, placentas and breast milk, indicating widespread contamination of people's bodies. The impact on health is as yet unknown but microplastics have been shown to cause damage to human cells in the laboratory. Vast amounts of plastic waste are dumped in the environment and microplastics have polluted the entire planet, from the summit of Mount Everest to the deepest oceans. People are known to consume the tiny particles via food and water as well as breathing them in. The particles could lodge in tissue and cause inflammation, as air pollution particles do, or chemicals in the plastics could cause harm. In March, doctors warned of potentially life-threatening effects after finding a substantially raised risk of stroke, heart attack and earlier death in people whose blood vessels were contaminated with microscopic plastics.

Hopes that replacement fuels for airplanes will slash carbon pollution are misguided and support for these alternatives could even worsen the climate crisis, a new report has warned. The Guardian: There is currently "no realistic or scalable alternative" to standard kerosene-based jet fuels, and touted "sustainable aviation fuels" are well off track to replace them in a timeframe needed to avert dangerous climate change, despite public subsidies, the report by the Institute for Policy Studies, a progressive thinktank, found. "While there are kernels of possibility, we should bring a high level of skepticism to the claims that alternative fuels will be a timely substitute for kerosene-based jet fuels," the report said.

Chuck Collins, co-author of the report, said: "To bring these fuels to the scale needed would require massive subsidies, the trade-offs would be unacceptable and would take resources aware from more urgent decarbonization priorities. It's a huge greenwashing exercise by the aviation industry. It's magical thinking that they will be able to do this." In the US, Joe Biden's administration has set a goal for 3bn gallons of sustainable aviation fuel, which is made from non-petroleum sources such as food waste, woody biomass and other feedstocks, to be produced by 2030, which it said will cut aviation's planet-heating emissions by 20%.

Google is opening up API access to its Google Home smart home platform, allowing app developers to access over 600 million connected devices and tap into the Google Home automation engine. In addition, Google announced that it'll be turning Google TVs into Google Home hubs and Matter controllers. The Verge reports: The Home APIs can access any Matter device or Works with Google Home device, and allows developers to build their own experiences using Google Home devices and automations into their apps on both iOS and Android. This is a significant move for Google in opening up its smart home platform, following shutting down its Works with Nest program back in 2019. [...] The Home APIs are already available to Google's early access partners, and Google is opening up a waitlist for any developer to sign up today. "We are opening up access on a rolling basis so they can begin building and testing within their apps," Anish Kattukaran, head of product at Google Home and Nest, told The Verge. "The first apps using the home APIs will be able to publish to the Play and App stores in the fall."

The access is not just limited to smart home developers. In the blog post, Matt Van Der Staay, engineering director at Google Home, said the Home APIs could be used to connect smart home devices to fitness or delivery apps. "You can build a complex app to manage any aspect of a smart home, or simply integrate with a smart device to solve pain points -- like turning on the lights automatically before the food delivery driver arrives." The APIs allow access to most devices connected to Google Home and to the Google Home structure, letting apps control and manage devices such as Matter light bulbs or the Nest Learning Thermostat. They also leverage Google Home's automation signals, such as motion from sensors, an appliance's mode changing, or Google's Home and Away mode, which uses various signals to determine if a home is occupied. [...]

What's also interesting here is that developers will be able to use the APIs to access and control any device that works with the new smart home standard Matter and even let people set up Matter devices directly in their app. This should make it easier for them to implement Matter into their apps, as it will add devices to the Google Home fabric, so they won't have to develop their own. In addition, Google announced that it's vastly expanding its Matter infrastructure by turning Google TVs into Google Home hubs and Matter controllers. Any app using the APIs would need a Google hub in a customer's home in order to control Matter devices locally. Later this year, Chromecast with Google TV, select panel TVs with Google TV running Android 14 or higher, and some LG TVs will be upgraded to become Google Home hubs.

Additionally, Kattukaran said Google will upgrade all of its existing home hubs -- which include Nest Hub (second-gen), Nest Hub Max, and Google Wifi -- with a new ability called Home runtime. "With this update, all hubs for Google Home will be able to directly route commands from any app built with Home APIs (such as the Google Home app) to a customer's Matter device locally, when the phone is on the same Wi-Fi network as the hub," said Kattukaran. This means you should see "significant latency improvements using local control via a hub for Google Home," he added.

Jess Weatherbed reports via The Verge: At least 224 people with diabetes have reported injuries linked to a defective iOS app that caused their insulin pumps to shut down prematurely, according to the US Food and Drug Administration (FDA). On Wednesday, the agency announced that California-based medical device manufacturer Tandem Diabetes Care has issued a recall for version 2.7 of the iOS t:connect mobile app, which is used in conjunction with the company's t:slim X2 insulin pump. Specifically, the recall relates to a software issue that can cause the app to repeatedly crash and relaunch, resulting in the pump's battery being drained by excessive Bluetooth communication.

This battery drain can cause the pump to shut down "earlier than typically expected" according to Tandem, though the pump will notify users of an imminent shutdown via an alarm and low-power alert. The company has notified customers to update the mobile app to version 2.7.1 or later, which should fix the defective software. While no physical recall is taking place, the FDA has identified this as a "Class I" recall -- the most serious type, as it relates to issues with products that can potentially cause serious injuries or death. No deaths linked to the issues have been reported as of April 15th. Tandem is encouraging pump users to take particular care when they sleep as it's easier to miss battery depletion warnings, and is asking impacted customers to confirm they have been notified of the recall via this online form. For any other questions or concerns about the insulin pump recall, customers should contact Tandem Diabetes Care directly.

Florida Gov. Ron DeSantis signed a bill this week banning and criminalizing the manufacture and sale of lab-grown meat in the state. From a report: The legislation joins similar efforts from three other states -- Alabama, Arizona and Tennessee -- that have also looked to stop the sale of lab-grown meat, which is believed to still be years away from commercial viability. "Florida is fighting back against the global elite's plan to force the world to eat meat grown in a petri dish or bugs to achieve their authoritarian goals," DeSantis said. "We will save our beef."

Lab-grown meat, also known as cultivated meat, has attracted considerable attention in recent years as startups have raised millions of dollars to improve the technology meant to create a climate-friendly alternative to traditional meat sources. Cultivated meat is usually grown in a metal vessel from a sample of animal cells. They multiply in a container called a bioreactor while being fed with water, amino acids, vitamins and lipids -- a process that can be difficult to do at scales large enough to create enough food for commercial sale. Still, some companies have made strides, with two California startups receiving approval from U.S. regulators last year to sell lab-grown chicken. Those companies said Florida's bill stifles innovation in a space that is becoming competitive globally.

Construction has begun on a $12 billion high-speed rail project to connect Las Vegas and Los Angeles by the end of the decade. The project, backed by $3 billion in federal support, aims to reduce travel time to under two hours and significantly cut greenhouse gas emissions. Popular Science reports: Brightline expects its trains will depart every 40 minutes from a station outside of the Vegas strip and another one in the LA suburb of Rancho Cucamonga. When it's completed, the train will travel at 186 miles per hour, making it the fastest train in the U.S. and comparable to Japan's famous bullet trains. For context, Brightline's most recently completed train connecting parts of Florida is estimated to top out around 130 miles per hour. Both of those still fall far short of the speed achieved by the world fastest commuter train in Shanghai, which can reportedly reach a speed of 286 miles per hour. Still, the new train could complete the 218 mile trip between Sin City and a suburb of the City of Angels in just 2 hours and 10 minutes. That same trip would take about four hours by car, and that's without substantial traffic.

Once built, the trains will reportedly include onboard Wi-Fi, restrooms, and food and drinks available for purchase. Brightline hasn't provided an exact price for how much an individual train ticket will cost but has instead said they expect it to be roughly equivalent to the price of an airline flight. Brightline reportedly believes the train could attract 11 million one-way passengers annually once it's up and running. The U.S. Department of Transportation estimates the new train could cut back 400,000 tons of carbon dioxide per year and create 35,000 new jobs. Department of Transportation Secretary Pete Buttigieg described the moment as a "major milestone in building the future of American rail." The ceremony symbolically took place on Earth Day. "Partnering with state leaders and Brightline West, we're writing a new chapter in our country's transportation story that includes thousands of union jobs, new connections to better economic opportunity, less congestion on the roads, and less pollution in the air," Buttigieg said in a statement.

A monthslong "Star Wars"-themed festival called Season of the Force is now happening at Disneyland — including John Williams compositions in the Star Wars: Galaxy's Edge land during the park's fireworks. SFGate reports: Before the show starts, a voice rings through the land. "Black Spire Outpost has a long and colorful history of heroes and legends, Jedi and Sith, royalty and resistance," it says. "Those who would rule and those who refuse to bow. Here we celebrate that fiery spirit tonight." Then as the first fireworks fly into the sky, the majestic "Star Wars" music begins...

During the day, the land is overrun with tiny robots. Season of the Force also includes daily appearances from the new BDX Droids, cute little "explorer companions," per Disneyland, designed to assist with "exploration and research." These new audio-animatronics interact with guests, clicking and whirring with a surprising amount of personality.

Sabine Wren from "Ahsoka" is also making appearances in Galaxy's Edge during Season of the Force, and there are specialty food offerings in the land like the Celto Slush (a green, pandan-flavored horchata cold brew coffee drink) and the return of Dewback Chili Noodles (spicy fettuccine with ginger-spiced ground pork, broccolini stems and shredded red cabbage).
For the event, Disneyland's long-running Star Tours ride now includes appearances from the Mandalorian (and Grogu), Ahsoka, and Cassian Andor, according to the article. "Also back this year is Hyperspace Mountain, the seasonal overlay of Space Mountain that puts riders into an intergalactic fight between the Resistance and the First Order."

An anonymous reader shares a report: Recent headlines have made clear: If AI is doing an impressively good job at a human task, there's a good chance that the task is actually being done by a human. When George Carlin's estate sued the creators of a podcast who said they used AI to create a standup routine in the late comedian's style, the podcasters claimed that the script had actually been generated by a human named Chad. (The two sides recently settled the suit.) A company making AI-powered voice interfaces for fast-food drive-thrus can only complete 30% of jobs without the help of a human reviewing its work. Amazon is dropping its automated "Just Walk Out" checkout systems from new stores -- a system that relied on far more human verification than it was hoping for.

We've seen this before -- though it may already be lost to Silicon Valley's pathologically short memory. Back in 2015, AI chatbots were the hot thing. Tech giants and startups alike pitched them as always-available, always-chipper, always-reliable assistants. One startup, x.ai, advertised an AI assistant who could read your emails and schedule your meetings. Another, GoButler, offered to book your flights or order your fries through a delivery app. Facebook also tested a do-anything concierge service called M, which could answer seemingly any question, do almost any task, and draw you pictures on demand. But for all of those services, the "AI assistant" was often just a person. Back in 2016, I wrote a story about this and interviewed workers whose job it was to be the human hiding behind the bot, making sure the bot never made a mistake or spoke nonsense.

A brain implant startup called Synchron is preparing to recruit patients for a large-scale clinical trial to seek commercial approval for its device. Reuters reports: Synchron on Monday plans to launch an online registry for patients interested in joining the trial meant to include dozens of participants, and has received interest from about 120 clinical trial centers to help run the study, CEO Thomas Oxley said in an interview. "Part of this registry is to start to enable local physicians to speak to patients with motor impairment," he said. "There's a lot of interest so we don't want it to come in a big bottleneck right before the study we'll be doing."

Synchron received U.S. authorization for preliminary testing in July 2021 and has implanted its device in six patients. Prior testing in four patients in Australia showed no serious adverse side effects, the company has reported. Synchron will be analyzing the U.S. data to prepare for the larger study, while awaiting authorization from the U.S. Food and Drug Administration to proceed, Oxley said. Synchron and the FDA declined to comment on the expected timing of that decision. The company aims to include patients who are paralyzed due to the neurodegenerative disease ALS (amyotrophic lateral sclerosis), stroke and multiple sclerosis, Oxley said. [...]

Synchron's device is delivered to the brain via the large vein that sits next to the motor cortex in the brain instead of being surgically implanted into the brain cortex like Neuralink's. The FDA has asked Synchron to screen stroke patients using a non-invasive test to determine whether they would respond to an implant, Oxley said. "They want to expand the market to people who have had a stroke severe enough to cause paralysis because if limited to quadriplegia, the market is way too small to be sustainable," Kip Ludwig, former program director for neural engineering at the U.S. National Institutes of Health, said of Synchron. In 2020, Synchron reported that patients, opens new tab in its Australian study could use its first-generation device to type an average of 16 characters per minute. That's better than non-invasive devices that sit atop the head and record the electrical activity of the brain, which have helped people type up to eight characters per minute, but not the leap forward that is hoped for with an implant, Ludwig said. Oxley would not say whether typing has gotten faster or offer any other details from the ongoing U.S. trial. Reuters notes that Synchron's investors include billionaires Jeff Bezos and Bill Gates. It's competing with Elon Musk's Neuralink brain implant startup and claims it's farther along in the process of testing its device.

Earlier this year, Neuralink said it implanted a chip in its first human patient. It later said the patient fully recovered and was able to control a computer mouse using their thoughts.

England could produce 13 times more renewable energy than it does now, while using less than 3% of its land, analysis has found. The Guardian: Onshore wind and solar projects could provide enough electricity to power all the households in England two and a half times over, the research by Exeter University, commissioned by Friends of the Earth (FoE), suggested. Currently, about 17 terawatt hours of electricity a year comes from homegrown renewables on land. But there is potential for 130TWh to come from solar panels, and 96TWh from onshore wind. These figures are reached by only taking into account the most suitable sites, excluding national parks, areas of outstanding natural beauty, higher grade agricultural land and heritage sites.

Some commentators have argued that solar farms will reduce the UK's ability to grow its own food, but the new analysis suggests there is plenty of land that can be used without impairing agricultural production. More land is now taken up by golf courses than solar farms, and developers can be required to enhance biodiversity through simple measures such as maintaining hedgerows and ponds. Onshore windfarms were in effect banned in 2015 by the then prime minister, David Cameron. Rishi Sunak last year claimed to make moves towards lifting the ban, through small changes to the planning regulations, but campaigners say they were ineffectual and real planning reform is needed. No plans were submitted for new windfarms in England last year, and few new developments are coming forward, despite high gas prices, rising bills and onshore wind being the cheapest form of electricity generation.